|
CN103908446A
|
|
Oral solid pharmaceutical composition containing Fingolimod
|
|
CN103880833A
|
|
Novel crystal form of dasatinib monohydrate, and preparation method and pharmaceutical composition thereof
|
|
CN103529134A
|
|
Content and impurity measuring method for tamibarotene and preparation thereof
|
|
CN103175927A
|
|
Method for content determination and impurity determination of taltirelin and preparation thereof
|
|
CN103175905A
|
|
Method for determining impurities in febuxostat and its preparation through high performance liquid chromatography
|
|
CN103059013A
|
|
New crystal of Dasatinib monohydrate and preparation method thereof
|
|
CN103007286A
|
|
Solid medicine composition of tolvaptan
|
|
CN103018347A
|
|
High-performance liquid chromatography analysis method for impurities in vorinostat and drug composition thereof
|
|
CN103018346A
|
|
High-performance liquid chromatography analysis method for impurities in vorinostat and drug composition thereof
|
|
CN102085209A
|
|
Medicinal composition for treating senile dementia
|
|
CN102085208A
|
|
Pharmaceutical composition for treating coronary heart disease and angina
|
|
CN102085207A
|
|
Medicinal composition
|
|
CN102085210A
|
|
Medicinal composition for treating cerebral infarction
|
|
CN102085206A
|
|
Medicinal composition
|
|
CN102086223A
|
|
Method for preparing ginsenoside Rg1
|
|
CN102020609A
|
|
Tolvapta crystal or amorphous substance and preparation method thereof
|
|
CN101961308A
|
|
Methylprednisolone aceponate cream preparation
|
|
CN101884630A
|
|
Taltirelin solid preparation
|
|
CN101862299A
|
|
Preparation method of aspoxicillin freeze-dried powder injection
|
|
CN101843592A
|
|
Preparation method of decitabine freeze-dried powder injection
|
